The 20 Best Richter Syndrome Doctors in New Jersey, US

Tatyana Feldman is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Feldman is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Lori Leslie is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Leslie is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Lymphadenectomy.

Andre Goy is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Goy is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Tissue Biopsy.

Kenneth Nahum is a Hematologist Oncology provider in Howell, New Jersey. Dr. Nahum is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Bone Marrow Aspiration, and Fasciotomy.

Richard Greenberg is a Hematologist and an Oncologist in Voorhees, New Jersey. Dr. Greenberg is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Iron Deficiency Anemia. Dr. Greenberg is currently accepting new patients.

Roger Strair is a Hematologist Oncology provider in Voorhees, New Jersey. Dr. Strair has been practicing medicine for over 45 years and is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Acute Myeloid Leukemia (AML), Multiple Myeloma, Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

With his many speaking engagements and commitment to education, Dr. Neil Morganstein has a reputation as a leader in the treatment of hematological and oncological issues. He is a national speaker in the area of multiple myeloma, as well as co-chair of a video conference on the management of patients with multiple myeloma. He has a special interest in lung cancer and multiple myeloma, and has published and presented several peer-reviewed articles, posters and abstracts at regional and national oncology meetings. These have focused on multiple myeloma, lymphoma, prostate cancer, gastric cancer, and hematological complications during pregnancy.As an involved and committed oncologist at Overlook Medical Center’s Carol G. Simon Cancer Center, Dr. Morganstein gives several lectures a year educating medical students. He teaches the hematology board review course for the American College of Physicians, as well as the hematology and oncology course for residents at Rutgers University. In addition, he thoroughly enjoys working with medical students in the hospital.Dr. Morganstein completed his hematology and oncology fellowship at Robert Wood Johnson University Hospital of New Brunswick, New Jersey, where he also finished his residency training, while serving as chief resident. He is board-certified in medical oncology, hematology and internal medicine and maintains membership in many distinguished organizations, including the American Society of Clinical Oncologists and the American Society of Hematologists. Dr. Morganstein is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration.

Joanne Filicko is an Oncologist and a Transplant Surgeon in Cherry Hill, New Jersey. Dr. Filicko is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. Her top areas of expertise are Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Multiple Myeloma, and Bone Marrow Transplant. Dr. Filicko is currently accepting new patients.

Aileen Chen is a Hematologist and an Oncologist in Freehold Township, New Jersey. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. Her top areas of expertise are Paget Disease of the Breast, Lung Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Chen is currently accepting new patients.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Bhavesh Balar is a Hematologist and an Oncologist in Freehold Township, New Jersey. Dr. Balar is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Myelodysplastic Syndrome (MDS), Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Balar is currently accepting new patients.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.

May Matkiwsky is a Hematologist and an Oncologist in Sparta, New Jersey. Dr. Matkiwsky is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. Her top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, Drug-Induced Thrombocytopenia, and Bone Marrow Aspiration. Dr. Matkiwsky is currently accepting new patients.

Meghan Thompson is a Hematologist and an Oncologist in Basking Ridge, New Jersey. Dr. Thompson has been practicing medicine for over 10 years and is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. Her top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Aspiration. Dr. Thompson is currently accepting new patients.

Seth Cohen is a Hematologist and an Oncologist in West Long Branch, New Jersey. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Cohen is currently accepting new patients.

Joanna Rhodes is a Hematologist in New Brunswick, New Jersey. Dr. Rhodes is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Rhodes is currently accepting new patients.

Matthew Matasar is a Hematologist and an Oncologist in New Brunswick, New Jersey. Dr. Matasar is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, B-Cell Lymphoma, and Bone Marrow Transplant. Dr. Matasar is currently accepting new patients.

Jeffrey Jones is a Hematologist and an Oncologist in Summit, New Jersey. Dr. Jones is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Leukemia, and Bone Marrow Aspiration.